Business
Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer
Reaffirms Full-Year 2025 Guidance FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today
About this update from Acadia Healthcare Company, Inc.
[{"type":"text","content":"\nReaffirms Full-Year 2025 Guidance\n\n\n FRANKLIN, Tenn.--(BUSINESS WIRE)--\nAcadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors.\n\n\nReeve Waud, Chairman of Acadia’s Board of Directors, said, “As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. Debbie is a mission-driven executive with a commitment to patients who helped transform Acadia into the leading provider of behavioral healthcare in the U.S. We are confident that with her deep knowledge of Acadia and track record of success, Debbie is the right person to step into the CEO role while the Board conducts a comprehensive search for a long-term successor and continues to evaluate all paths to deliver enhanced shareholder value.”\n\n\nWaud concluded, “We appreciate Chris’s unwavering commitment to Acadia and its patients. During his tenure as CEO, Acadia increased its capacity to serve more patients in need, added new facilities developed with trusted joint venture partners, and made meaningful investments in its quality platform to strengthen care delivery and demonstrate the value of the Company’s services. We wish Chris the best in his future endeavors.”\n\n\nOsteen said, “I am excited to step back into the role of CEO of Acadia. As the largest stand-alone behavioral healthcare company in the U.S., and with joint venture partnerships with deeply respected health systems across the country, the Company is poised for long-term success. I look forward to working closely with our talented team and the Board of Directors to continue to provide care for the most vulnerable patients in our communities and drive value creation.”\n\n\nReaffirms Full-Year 2025 Outlook\n\n\nThe Company is reaffirming its 2025 financial guidance as updated by its December 2, 2025 press release and reiterated in conjunction with management’s presentation at the 44th Annual J.P. Morgan Healthcare Conference on Janu...